1. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer
   Yuanping Hu et al, 2020, Clinical Breast Cancer CrossRef
2. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis
   Xue Qi et al, 2023, BMJ Open CrossRef
3. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer
   Yanyun Zhu et al, 2017, Oncotarget CrossRef
4. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer
   Yisheng Wei et al, 2018, Asia-Pacific Journal of Clinical Oncology CrossRef
5. White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer
   A. Sibille et al, 2021, Lung CrossRef
6. Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
   Antonino Grassadonia et al, 2021, Cells CrossRef
7. Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma
   Mégane Willems et al, 2023, Frontiers in Immunology CrossRef
8. Immunity and Breast Cancer: Focus on Eosinophils
   Aurélie Poncin et al, 2021, Biomedicines CrossRef
9. Comparison of the effect of erector spinae plane block for postoperative analgesia on neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients operated for breast cancer
   Kübra ŞAHİN KARADİL et al, 2024, The European Research Journal CrossRef
10. Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
    Concetta Elisa Onesti et al, 2018, Oncotarget CrossRef
11. Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: neutrophil/lymphocyte ratio is associated with multiple recurrences
    Faris F. Brkic et al, 2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
12. The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer
    Ryotaro Ohkuma et al, 2021, Pancreas CrossRef
13. Eosinophilia in cancer and its regulation by sex hormones
    Sandeep Artham et al, 2023, Trends in Endocrinology & Metabolism CrossRef
14. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis
    Zhixun Gong et al, 2022, The International Journal of Biological Markers CrossRef
15. Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse
    Concetta Elisa Onesti et al, 2020, OncoImmunology CrossRef
16. Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
    Wanying Guo et al, 2019, Cancer Medicine CrossRef
17. Opposing roles of eosinophils in cancer
    Sonja C. S. Simon et al, 2019, Cancer Immunology, Immunotherapy CrossRef
18. Reduction of Inflammatory Response by Way of Oxidative Stress with San Huang Decoction (SHD) In Perioperative Care: A Randomized Clinical Trial
    Chang Yao, 2017, International Journal of Complementary & Alternative Medicine CrossRef
19. Associations of Complete Blood Count Parameters with Disease-Free Survival in Right- and Left-Sided Colorectal Cancer Patients
    Alhasan Alsalman et al, 2022, Journal of Personalized Medicine CrossRef
20. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis
    Miao Zhang et al, 2017, BioMed Research International CrossRef